Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Option Award | 2024-11-27 6:06 pm | N/A 2034-02-28 | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 90,090 | $0 | 90,090 (Direct) | View |
| 2024-11-14 Tax Withholding | 2024-11-18 4:28 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 613 | $7.92 | 67,871 (Direct) | View |
| 2024-08-14 Tax Withholding | 2024-08-16 4:48 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 613 | $7.02 | 68,484 (Direct) | View |
| 2024-05-17 Exercise | 2024-05-21 4:04 pm | N/A 2031-01-13 | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 10,000 | $0 | 155,712 (Direct) | View |
| 2024-05-17 Exercise | 2024-05-21 4:04 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 10,000 | $1.04 | 155,712 (Direct) | View |
| 2024-05-14 Tax Withholding | 2024-05-16 6:56 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 613 | $8.36 | 59,097 (Direct) | View |
| 2024-02-14 Tax Withholding | 2024-02-16 5:08 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 723 | $3.4 | 59,710 (Direct) | View |
| 2023-11-14 Tax Withholding | 2023-11-16 7:41 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 2,450 | $5.08 | 60,433 (Direct) | View |
| 2023-06-05 Exercise | 2023-06-06 4:15 pm | N/A 2031-01-13 | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 9,225 | $0 | 159,498 (Direct) | View |
| 2023-06-05 Exercise | 2023-06-06 4:15 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 9,225 | $1.04 | 159,498 (Direct) | View |
| 2022-11-14 Option Award | 2022-11-16 7:18 pm | N/A 2032-11-13 | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 133,533 | $0 | 153,808 (Direct) | View |
Ownership | 2022-11-09 8:30 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 0 | $0 | 220,701 (Direct) | View |